1.Clinical Observation of Recombinant Human Interferon α2b Combined with Bozhi Glycopeptides and Thymopentin in the Treatment of HBeAg-positive Chronic Hepatitis B
China Pharmacy 2017;28(8):1120-1123
OBJECTIVE:To observe the clinical efficacy and safety of recombinant human interferon α2b (rhIFN α2b) combined with bozhi glycopeptides or thymopentin in the treatment of chronic hepatitis B (CHB).METHODS:Ninety HBeAg-positive CHB patients were selected from our hospital during Jan.2014-Jan.2015 and then randomly divided into group A,B,C,with 30 cases in each group.Group A was given rhINF α2b for injection (Pseudomonas) 5 million IU subcutaneously,qod;group B was additionally given Bozhi glycopeptides injection 4 mL added into 5% Glucose injection 250 mL,ivgtt,qd,on the basis of group A;group C was additionally given Thymopentin for injection 2 mg added into 5% Glucose injection 250 mL,ivgtt,qd,on the basis of group A.Three groups were treated for 24 weeks.The rate of ALT recovering to normal,negative rate of HBeAg,transformation rate of HBeAg/anti-HBeAg serum,negative rate of HBV-DNA and the decrease of HBsAg and HBV-DNA were compared among 2 groups after 4,8,12,24 weeks of treatment.The occurrence of ADR was recorded.RESULTS:After 4,8,12 weeks of treatment,there was no statistical significance in the rate of ALT recovering to normal,negative rate of HBeAg,transformation rate of HBeAg and the decrease of HBsAg among 3 groups (P>0.05).After 4 weeks,negative rate of HBV-DNA in group B,C were significantly higher than group A;the decrease of HBV-DNA in group C were more significant than group A and B,with statistical significance (P<0.05).After 8,12 weeks of treatment,the negative rate of HBV-DNA and the decrease of HBV-DNA in group B,C were significantly higher than group A,with statistical significance (P<0.05);but there was no statistical signifi cance between group B and C (P>0.05).After 24 weeks of treatment,there was no statistical significance in the rate of ALT recovering to normal,transformation rate of HBeAg,the decrease of HBsAg and negative rate of HBsAg among 3 groups (P>0.05).The negative rate of HBsAg,negative rate of HBV-DNA and the decrease of HBV-DNA in group B,C were significantly higher than group A,with statistical significance (P<0.05);there was no statistical significance between group B and C (P>0.05).There was no statistical significance in the incidence of ADR among 3 groups(P>0.05).CONCLUSIONS:rhIFN α2bcombined with bozhi glycopeptides or thymopentin shows good inhibitory effect on CHB,therapeutic efficacies of them are similar in the rate of ALT recovering to normal,but transformation rate of HBeAg,the decrease of HBsAg and negative rate of HBeAg.
2.A survey of requirement and problem in clinic medical practice about undergraduate nursing education
Chinese Journal of Medical Education Research 2011;10(9):1145-1147
ObjectiveUnderstanding demand conditions for medical practice of the current medical schools nursing undergraduate and practical status of education,providing realistic and reliable basis for the reform of the nursing practice,and inquirying the practical measures of the teaching reform.MethodsAnalysing the 118 questionnaires issued by nursing students participated in medical practice and investigating the purpose of the nursing students wanting to achieve,the teaching form approved,the deficiencies proposed and overall satisfaction of teaching.ResultsThere is a considerable gap between nursing students' satisfaction,the strong demand,great interest of medical practice and current situation.ConclusionWe should concerne about the interns' strong demand for medical practice,pay attention to the teaching content,methods,objectives and organizational arrangements for many aspects of the construction and improvement.
3.Multidrug resistance mediated by ABCG2
Journal of International Oncology 2013;(6):403-406
ABCG2 is a member of the ATP-binding cassette (ABC) transporter family.The overexpression of ABCG2 is identified as one of the important mechanisms that limiting cellular accumulation of various compounds.With regard to its broad substrate spectrum including various anticancer drugs and environmental carcinogens,the function of ABCG2 is associated with multidrug resistance (MDR) and tumor development.ABCG2 as a target site to reverse MDR has been widely concered.
4.Effects of serum containing Yiqi Xiaoji Recipe on cell line NKN-28 of gastric cancer
Journal of Integrative Medicine 2007;5(4):442-4
OBJECTIVE: To explore the effects of serum containing Yiqi Xiaoji Recipe (YQXJR), a compound traditional Chinese herbal medicine for benefiting qi and removing stagnation, on cell line NKN-28 of gastric cancer. METHODS: The experimental SD rats were taken as the provider of the animal serum, and the serum was inactivated before the experiment. The serum was divided into high-dose, medium-dose, low-dose and blank serum groups based on whether the rats were given YQXJR and administration dosage. The inhibition rate was regarded as the observational index. RESULTS: The four groups of serum all had inhibitory effect on the growth of NKN-28 cells depending on the drug concentration. And there were significant differences among the experimental groups. High-dose, medium-dose and low-dose concentrations of serum all could inhibit the growth of NKN-28 cells with positive relations with the concentration and function time. CONCLUSION: YQXJR serum can inhibit the growth of NKN-28 cells depending on the drug concentration and function time.
5.The requirements to clinicopathology about targeted therapy for breast cancer.
Chinese Journal of Pathology 2007;36(7):435-437
Antibodies, Monoclonal
;
therapeutic use
;
Antibodies, Monoclonal, Humanized
;
Antineoplastic Agents
;
therapeutic use
;
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Breast Neoplasms
;
drug therapy
;
metabolism
;
pathology
;
Carcinoma, Ductal, Breast
;
drug therapy
;
metabolism
;
pathology
;
Female
;
Humans
;
Receptor, ErbB-2
;
metabolism
;
Trastuzumab
6.Congenital bilateral ejaculatory duct absence complicated with seminal vesicle cyst: a case report and review of the literature.
Kai LIAO ; Hua SHEN ; Hong-fei WU
National Journal of Andrology 2015;21(2):161-164
OBJECTIVETo report a case of simple congenital bilateral ejaculatory duct absence (EDA) complicated with seminal vesicle cyst and review the relevant literature in order to improve the diagnosis and treatment of the disease.
METHODSWe retrospectively reviewed the clinical data of a case of bilateral congenital EDA complicated with seminal vesicle cyst, reviewed the relevant literature at home and abroad, and comprehensively analyzed the embryonic development, diagnosis, and treatment of congenital EDA.
RESULTSThe patient was a 23-year-old man, present at the clinic for infertility after married for a year. Vasography and other imaging examinations confirmed simple congenital bilateral EDA complicated with seminal vesicle cyst. Pathologic biopsy showed normal spermatogenic function of the testes.
CONCLUSIONCongenital EDA originates from embryonic developmental defect of the mesonephric duct, and it can be confirmed by vasography. Transurethral incision of the ejaculatory duct and intracytoplasmic sperm injection can be employed for the treatment of bilateral EDA.
Cysts ; complications ; diagnosis ; Ejaculatory Ducts ; abnormalities ; Genital Diseases, Male ; complications ; diagnosis ; Humans ; Male ; Retrospective Studies ; Seminal Vesicles
8.Clinical effect of biapenem and levofloxacin in hospital acquired pneumonia caused by extensive drug resistant bacillus
Fei ZHU ; Jing SHEN ; Huayi WU
Chinese Journal of Biochemical Pharmaceutics 2016;36(11):81-83,87
Objective To investigate the clinical effect of biapenem and levofloxacin in the treatment of pulmonary infection caused by extensive drug resistant bacillus.Methods 182 patients with pulmonary infection caused by extensive drug resistant bacillus from the department of respiratory in our hospital were selected and divided into two groups, 91 cases in the control group were given cefoperazone sodium and sulbactam sodium +levofloxacin treatment, 91 cases in the experiment group received biapenem +levofloxacin treatment, serum levels of white blood cell count(WBC), high sensitivity C-reactive protein(hs-CRP),procalcitonin(PCT),serum amyloid A(SAA), recovery time of clinical symptoms, signs and laboratory examination, the clinical effect, bacteriological effect and incidence of adverse reactions were compared after treatment.Results The effective rate in the control group(74.72%)was lower than the experiment group(86.81%), with significant difference (P<0.05); compared with the control group, the bacterial clearance rate was higher, bacterial unclearance rate, partial clearance rate, replacement rate were higher in the experiment group after treatment, serum levels of WBC,hs-CRP,PCT,SAA were lower after treatment, recovery time of body temperature, pulmonary signs, abnormal shadow of chest X-ray, WBC, hs-CRP were shorter, with significant difference ( P<0.05 ); there was no significant difference in the incidence of adverse reactions between the two groups.Conclusion The clinical effect of biapenem and levofloxacin in the treatment of pulmonary infection caused by extensive drug resistant bacillus was exactly, can effectively remove bacteria, control infection, shorten the treatment time, and the safety was high.
9.Research progress of diffuse sclerosing variant papillary thyroid carcinoma
Jianhua FENG ; Fei SHEN ; Bo XU
International Journal of Surgery 2017;44(5):353-357
Diffuse sclerosing variant papillary thyroid carcinoma,one of the variants of papillary thyroid carcinoma,nearly account for 0.7% to 6.6% of papillary thyroid carcinoma.It is an aggressive tumor that shows higher rates of recurrence,metastasis and persistent disease compares to classic papillary thyroid carcinoma,thus diffuse sclerosing variant papillary thyroid carcinoma needs stricter and more exhaustive operation.Since the incidence of diffuse sclerosing variant papillary thyroid carcinoma is low,many physicians lack of understanding of the disease,it's often missed diagnosis or misdiagnosed.Consequently.In order to let physicians understand more about diffuse sclerosing variant papillary thyroid carcinoma,this paper will elaborate the epidemiology,clinic and pathology features of it.
10. The effect of Kanglaite Injection in combination with gefitinib on angiogenesis in mice with Lewis lung cancer
Tumor 2013;33(12):1047-1053
Objective: By observing the effect of Kanglaite (KLT) Injection in combination with gefitinib on angiogenesis in mice with Lewis lung cancer, to explore its possible mechanism. Methods: Lewis lung cancer model was established in C57BL/6 mice. Forty model mice were randomized into 4 groups: control group, KLT treatment group, gefitinib treatment group, and KLT+gefitinib treatment group. Using immunohistochemistry and RT-PCR technology to observe and compare tumor growth and angiogenesis in each treatment group. Results: The average weight of the tumor in KLT+gefitinib treatment group was lower than those in the KLT treatment group and the gefitinib treatment group; the difference was statistically significant (P < 0.01). Judging from the inhibition rate, KLT, gefitinib, and KLT+gefitinib can inhibit the growth of the transplanted tumor, especially for the combination treatment. The microvessel density (MVD)-positive labeling index (LI) in control group, KLT treatment group, gefitinib treatment group and the KLT+gefitinib treatment group were 24.35±1.06, 18.25±1.36, 20.09±1.46 and 14.46±0.98, respectively. The MVD of the KLT+gefitinib treatment group was lower than those of the two single drug groups; the difference was statistically significant (P < 0.01). The expression levels of VEGF and KDR proteins in the KLT treatment group and the gefitinib treatment group were lower than that of the control group (P <0.05) and higher than that of the KLT+gefitinib group (P < 0.05). The expression levels of VEGF and KDR mRNAs in the KLT+gefitinib group was lower than those of the two single drug groups; the difference was statistically significant (P < 0.05). Conclusion: KLT combined with gefitinib treatment may exert synergistic effect on anti-angiogenesis, so as to obtain synergistic anti-tumor effect. Copyright © 2013 by TUMOR.